Viatris (VTRS) Inventory Average (2021 - 2026)
Viatris (VTRS) posted Inventory Average of $3.9 billion for Q2 2026, down 0.83% on a QoQ basis from $4.0 billion in Q1 2026, and down 5.99% year-over-year from $4.2 billion in Q2 2025.
Analysis
Viatris (VTRS) Inventory Average (2021 - 2026) Analysis & Trends
Viatris has reported Inventory Average for 6 years, with the latest figure at $3.9 billion in Q2 2026.
- On a quarterly basis, Inventory Average fell 5.99% year-over-year to $3.9 billion in Q2 2026; TTM through Jun 2026 was $3.9 billion, a 5.99% decrease from a year earlier, with the FY2025 full-year figure at $3.9 billion, up 7.23% from the prior year.
- Inventory Average was $3.9 billion for Q2 2026 at Viatris, down from $4.0 billion in the prior quarter.
- The five-year high for Inventory Average was $4.2 billion in Q3 2025, with the low at $3.4 billion in Q4 2022.
- Average Inventory Average over 5 years is $3.8 billion, with a median of $3.9 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Inventory Average fell 25.34% in 2022, then advanced 11.16% in 2024.
- Over 5 years, Inventory Average stood at $3.4 billion in 2022, then climbed by 3.5% to $3.6 billion in 2023, then increased by 11.16% to $4.0 billion in 2024, then gained by 2.17% to $4.1 billion in 2025, then fell by 3.09% to $3.9 billion in 2026.
- The last three Inventory Average figures came in at $3.9 billion (Q2 2026), $4.0 billion (Q1 2026), and $4.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 3.20 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 3.93 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 843.60 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 659.79 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1.60 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 227.28 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 143.31 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 175.05 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Bn |
| Mar 31, 2026 | 3.96 Bn |
| Dec 31, 2025 | 4.06 Bn |
| Sep 30, 2025 | 4.19 Bn |
| Jun 30, 2025 | 4.18 Bn |
| Mar 31, 2025 | 3.98 Bn |
| Dec 31, 2024 | 3.97 Bn |
| Sep 30, 2024 | 4.01 Bn |
| Jun 30, 2024 | 3.88 Bn |
| Mar 31, 2024 | 3.65 Bn |
| Dec 31, 2023 | 3.57 Bn |
| Sep 30, 2023 | 3.66 Bn |
| Jun 30, 2023 | 3.65 Bn |
| Mar 31, 2023 | 3.59 Bn |
| Dec 31, 2022 | 3.45 Bn |
| Sep 30, 2022 | 3.50 Bn |
| Jun 30, 2022 | 3.70 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 4.03 Bn |
| Sep 30, 2021 | 4.28 Bn |